Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

9.685 +0.385 (+4.14%)
Streaming Delayed Price Updated: 3:40 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 Next >
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
Via Benzinga
Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
Via Benzinga
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
Via Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024
NRIX stock results show that Nurix Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Decoding 4 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
The Latest Analyst Ratings for Nurix Therapeutics
Via Benzinga
What 4 Analyst Ratings Have To Say About Nurix Therapeutics
Via Benzinga
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
From Toll Brothers, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action
Via Investor Brand Network
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Via Benzinga
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called... 
Via Benzinga
Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
Expert Ratings for Nurix Therapeutics
Via Benzinga
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
Via Benzinga
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
From Gilead Sciences, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
Via Benzinga
Analyst Ratings for Nurix Therapeutics
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.